Scarica l'app Stockscreener
80.02
0.11%
-0.09
Dopo l'orario di chiusura:
80.02
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$80.11
Aprire:
$74.53
Volume 24 ore:
1.07M
Relative Volume:
1.09
Capitalizzazione di mercato:
$2.15B
Reddito:
$267.23M
Utile/perdita netta:
$-83.50M
Rapporto P/E:
-25.73
EPS:
-3.11
Flusso di cassa netto:
$-59.99M
1 W Prestazione:
-13.21%
1M Prestazione:
-19.17%
6M Prestazione:
+60.62%
1 anno Prestazione:
+784.20%
Intervallo 1D:
$72.18
$81.47
Intervallo di 1 settimana:
$72.18
$92.52
Portata 52W:
$8.6328
$115.60
Genedx Holdings Corp Stock (WGS) Company Profile
Nome
Genedx Holdings Corp
Settore
Industria
Telefono
888-729-1206
Indirizzo
333 LUDLOW STREET, STAMFORD
Confronta WGS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
WGS
Genedx Holdings Corp
|
80.02 | 2.15B | 267.23M | -83.50M | -59.99M | -3.11 |
|
TMO
Thermo Fisher Scientific Inc
|
437.91 | 171.01B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
181.77 | 134.77B | 23.88B | 3.90B | 5.30B | 5.28 |
|
IDXX
Idexx Laboratories Inc
|
393.73 | 32.47B | 3.90B | 887.87M | 798.08M | 10.67 |
|
A
Agilent Technologies Inc
|
103.00 | 29.63B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
154.73 | 28.04B | 15.41B | 1.37B | 2.11B | 7.50 |
Genedx Holdings Corp Stock (WGS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-08-28 | Iniziato | Wells Fargo | Equal Weight |
| 2024-07-10 | Iniziato | Craig Hallum | Buy |
| 2024-06-03 | Ripresa | Jefferies | Hold |
Genedx Holdings Corp Borsa (WGS) Ultime notizie
Why GeneDx Holdings Shares Are Under Pressure - TipRanks
GeneDx Expands Commercial Footprint for Exome and Genome Testing with Inborn Errors of Immunity as a New Indication - Yahoo Finance
Prudential Financial Inc. Takes Position in GeneDx Holdings Corp. (NASDAQ:WGS) - MarketBeat
GeneDx CEO Stueland sells $4.45 million in stock By Investing.com - Investing.com Australia
GeneDx holdings CFO Kevin Feeley sells $836,210 in stock By Investing.com - Investing.com Australia
GeneDx holdings CFO Kevin Feeley sells $836,210 in stock - Investing.com India
GeneDx CEO Stueland sells $4.45 million in stock - Investing.com India
GeneDx Holdings Corp. Executives Sell Shares to Cover Tax Obligations - TradingView
Victory Capital Management Inc. Acquires Shares of 2,720 GeneDx Holdings Corp. (NASDAQ:WGS) - MarketBeat
7 Up-and-Coming Stocks to Buy in 2025 - US News Money
How To Trade (WGS) - news.stocktradersdaily.com
3 Stocks Estimated To Be Trading At A Discount Of 25.2% To 28.2% - simplywall.st
Is GeneDx Holdings (WGS) The High Growth Low Debt Stock to Invest in Now? - Insider Monkey
GeneDx Holdings Corp. (NASDAQ:WGS) CEO Sells $96,416.32 in Stock - MarketBeat
GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) -March 20, 2025 at 04:52 pm EDT - Marketscreener.com
GeneDx Strengthens Team: 10 New Hires Receive Strategic Stock Awards Worth 46,340 RSUs - Stock Titan
Zacks.com featured highlights DRDGOLD, GeneDx, EverQuote, HCI Group and Alibaba - Yahoo Finance
12 High Growth Low Debt Stocks to Invest in Now - Insider Monkey
Is Now The Time To Look At Buying GeneDx Holdings Corp. (NASDAQ:WGS)? - Yahoo Finance
Fast Company Recognizes GeneDx as One of the World's Most Innovative Companies - Yahoo Finance
GeneDx Holdings Corp. Executives Sell Shares for Tax Obligations - TradingView
Is GeneDx Holdings (NASDAQ:WGS) Using Too Much Debt? - Simply Wall St
Raymond James Financial Inc. Acquires New Position in GeneDx Holdings Corp. (NASDAQ:WGS) - Defense World
3,501 Shares in GeneDx Holdings Corp. (NASDAQ:WGS) Bought by Arizona State Retirement System - Defense World
GeneDx Holdings Corp. (NASDAQ:WGS) Receives Consensus Recommendation of “Moderate Buy” from Brokerages - Defense World
Short Interest in GeneDx Holdings Corp. (NASDAQ:WGSWW) Drops By 43.2% - Defense World
Is GeneDx Holdings Corp. (WGS) the Best Multibagger Stock to Buy in 2025? - Insider Monkey
Revolutionary AI Tool by GeneDx Transforms Genetic Testing with 750,000 Clinical Sequences - StockTitan
GeneDx Enhances the Power of its Interpretation Platform with Artificial Intelligence (AI) Powered Gene Ranker to Enable Faster and More Efficient Clinical Analysis - Yahoo Finance
GeneDx Holdings: There Is Upside Potential, But Price Tag Is Rich (NASDAQ:WGS) - Seeking Alpha
Genedx CFO Kevin Feeley sells shares worth $87k By Investing.com - Investing.com Australia
GeneDx CEO Katherine Stueland sells $258,695 in company stock By Investing.com - Investing.com South Africa
12 Best Multibagger Stocks to Buy in 2025 - Insider Monkey
Genedx CFO Kevin Feeley sells shares worth $87k - Investing.com
GeneDx CEO Katherine Stueland sells $258,695 in company stock - Investing.com
Is GeneDx Holdings Corp. (WGS) the Best Emerging Technology Stock to Buy Now? - Insider Monkey
10 Best Emerging Technology Stocks to Buy Now - Insider Monkey
Lisanti Capital Growth LLC Raises Stock Position in GeneDx Holdings Corp. (NASDAQ:WGS) - MarketBeat
GeneDx at TD Cowen Conference: Strategic Expansion in Genomics By Investing.com - Investing.com South Africa
GeneDx at TD Cowen Conference: Strategic Expansion in Genomics - Investing.com India
GeneDx Holdings Corp. (NASDAQ:WGS) Shares Bought by Principal Financial Group Inc. - Defense World
Rhumbline Advisers Buys 1,021 Shares of GeneDx Holdings Corp. (NASDAQ:WGS) - Defense World
GeneDx Holdings Shares Surge Amid Strong Prospects - TipRanks
GeneDx Expanding Genetic Testing to Include Cerebral Palsy -March 04, 2025 at 09:53 am EST - Marketscreener.com
GeneDx Expands Commercial Footprint for Exome and Genome Testing with Cerebral Palsy as a New Indication - Business Wire
GeneDx Holdings Corp. (NASDAQ:WGS) Sees Significant Increase in Short Interest - Defense World
GeneDx Holdings Corp. (NASDAQ:WGSWW) Short Interest Update - Defense World
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GeneDx Holdings CorpWGS - PR Newswire
Genedx Holdings Corp Azioni (WGS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Genedx Holdings Corp Azioni (WGS) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Feeley Kevin | CHIEF FINANCIAL OFFICER |
Mar 26 '25 |
Sale |
95.61 |
8,746 |
836,211 |
15,996 |
| Stueland Katherine | Chief Executive Officer |
Mar 26 '25 |
Option Exercise |
0.00 |
80,000 |
0 |
94,865 |
| Stueland Katherine | Chief Executive Officer |
Mar 26 '25 |
Sale |
95.62 |
46,551 |
4,451,084 |
48,314 |
3.49%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):